20-kDa placental hGH-V has diminished diabetogenic and lactogenic activities compared with 22-kDa hGH-N while retaining antilipogenic activity
- PMID: 19509186
- DOI: 10.1152/ajpendo.00221.2009
20-kDa placental hGH-V has diminished diabetogenic and lactogenic activities compared with 22-kDa hGH-N while retaining antilipogenic activity
Abstract
Placental human growth hormone-variant (hGH-V) and pituitary human growth hormone-N (hGH-N) are of identical size (22 kDa) but differ in 13 residues scattered throughout the protein. Several isoforms of GH are produced by the hGH-N and hGH-V genes including a 20-kDa hGH-V resulting from a 45-bp deletion caused by the use of an alternative acceptor site within exon 3. To date, the biological properties of the 20-kDa GH-V have not been characterized in vivo. Using young male Wistar rats fed either chow or a high-fat (HF) diet for 4 wk postweaning, we investigated the effect of 7 days treatment with either 22-kDa hGH-N, 20-kDa hGH-V (5 ug x g(-1) x day(-1) sc), or vehicle on body composition and endocrine and metabolic profiles. Total body growth (absolute weight gain and linear growth trajectory) in the 20-kDa hGH-V-treated animals was intermediary between that of control and hGH-N-treated animals. Both 22-kDa hGH-N and 20-kDa hGH-V significantly reduced total body fat mass compared with control animals, and there were no differences between the GH isoforms in anti-lipogenic activity in animals fed the HF diet. Fasting plasma insulin and C peptide were significantly increased in animals on the HF diet and further increased by hGH-N but were unchanged in 20-kDa hGH-V-treated animals compared with saline-treated controls. Plasma volume as assessed by hematocrit was increased in hGH-N-treated animals but was unchanged in 20-kDa hGH-V-treated animals compared with controls. Furthermore, 20-kDa hGH-V had reduced lactogenic (prolactin receptor mediated) activity characteristic of hGH-N as tested in vitro compared with the 20-kDa hGH-N and 22-kDa hGH-N variants. In summary, placental 20-kDa hGH-V retains some of the growth-promoting and all antilipogenic activities of pituitary 22-kDa hGH-N but has diminished diabetogenic and lactogenic properties compared with the native 22-kDa hGH-N.
Similar articles
-
Somatogenic and lactogenic activity of the recombinant 22 kDa isoform of human placental growth hormone.Growth Regul. 1995 Mar;5(1):60-5. Growth Regul. 1995. PMID: 7749349
-
Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.Growth Horm IGF Res. 2006 Oct-Dec;16(5-6):297-307. doi: 10.1016/j.ghir.2006.07.002. Epub 2006 Sep 28. Growth Horm IGF Res. 2006. PMID: 17010651
-
Diabetogenic activity of 20 kDa human growth hormone (20K-hGH) and 22K-hGH in rats.Growth Horm IGF Res. 2001 Apr;11(2):110-6. doi: 10.1054/ghir.2001.0198. Growth Horm IGF Res. 2001. PMID: 11472077
-
Growth hormone isoforms.Growth Horm IGF Res. 2009 Aug;19(4):333-40. doi: 10.1016/j.ghir.2009.04.011. Epub 2009 May 24. Growth Horm IGF Res. 2009. PMID: 19467614 Review.
-
The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development.J Pediatr Endocrinol Metab. 2000 Apr;13(4):343-56. doi: 10.1515/jpem.2000.13.4.343. J Pediatr Endocrinol Metab. 2000. PMID: 10776988 Review.
Cited by
-
Growth hormone: isoforms, clinical aspects and assays interference.Clin Diabetes Endocrinol. 2018 Aug 28;4:18. doi: 10.1186/s40842-018-0068-1. eCollection 2018. Clin Diabetes Endocrinol. 2018. PMID: 30181896 Free PMC article. Review.
-
Musculoskeletal Effects of Altered GH Action.Front Physiol. 2022 May 19;13:867921. doi: 10.3389/fphys.2022.867921. eCollection 2022. Front Physiol. 2022. PMID: 35665221 Free PMC article. Review.
-
The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH?Endocrinology. 2020 Aug 1;161(8):bqaa097. doi: 10.1210/endocr/bqaa097. Endocrinology. 2020. PMID: 32556100 Free PMC article.
-
The 20 kDa isoform of the human growth hormone variant alters adipose and muscle gene expression differently than human growth hormone.J Neuroendocrinol. 2025 Jun 16:e70059. doi: 10.1111/jne.70059. Online ahead of print. J Neuroendocrinol. 2025. PMID: 40524488
-
CCAAT-enhancer-binding protein β (C/EBPβ) and downstream human placental growth hormone genes are targets for dysregulation in pregnancies complicated by maternal obesity.J Biol Chem. 2013 Aug 2;288(31):22849-61. doi: 10.1074/jbc.M113.474999. Epub 2013 Jun 19. J Biol Chem. 2013. PMID: 23782703 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous